Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 20/20 | 0.68 |
| ▸ | F9 | P00740 | 9/20 | 0.68 |
| ▸ | F10 | P00742 | 8/20 | 0.68 |
| ▸ | F2 | P00734 | 6/20 | 0.68 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.68 |
| ▸ | PRSS2 | P07478 | 5/20 | 0.68 |
| ▸ | PRSS3 | P35030 | 5/20 | 0.68 |
| ▸ | F11 | P03951 | 5/20 | 0.68 |
| ▸ | PLAU | P00749 | 3/20 | 0.68 |
| ▸ | F3 | P13726 | 4/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7654587 | 0.96 | F7 (0.68) | F7F9F10F2PRSS1 | |
| SCHEMBL7659002 | 0.95 | F7 (0.69) | F7F9F10F2PRSS1 | |
| SCHEMBL7660730 | 0.92 | F7 (0.78) | F7F9F10F2PRSS1 | |
| SCHEMBL7657454 | 0.92 | F7 (0.81) | F7F9F10F2PRSS1 | |
| SCHEMBL7662385 | 0.91 | F7 (0.70) | F7F9F10F2PRSS1 | |
| SCHEMBL7651283 | 0.91 | F7 (0.83) | F7F9F10F2PRSS1 | |
| SCHEMBL7651271 | 0.91 | F7 (0.83) | F7F9F10F2PRSS1 | |
| SCHEMBL7656293 | 0.89 | F7 (0.66) | F7F9F10F2PRSS1 | |
| SCHEMBL7854539 | 0.89 | F7 (0.53) | F7F9F10F2PRSS1 | |
| SCHEMBL7654579 | 0.89 | F7 (0.77) | F7F9F10F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358960-B1 | FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |